People with a history of alcoholism
If benefits fade rapidly, shorter breaks may be appropriate

You should contact your GP or prescriber if : You experience significant difficulty eating or maintaining adequate nutrition Your weight loss exceeds 0.51 kg per week consistently after the initial treatment period You develop persistent nausea, vomiting, or abdominal pain You notice significant changes in heart rate, palpitations, or blood pressure readings Sleep disturbances worsen or become unmanageable You experience mood changes, increased anxiety, or depression Side effects from either medication become intolerable You're considering adjusting the dose of either medication You are planning a pregnancy or become pregnant Before starting combined therapy , ensure your prescriber is aware of: Your complete medication list, including over-the-counter medicines and supplements Your full medical history, particularly cardiovascular, gastrointestinal, and psychiatric conditions Any history of eating disorders or disordered eating patterns Previous responses to appetite-suppressant medications Your weight management goals and expectations Family planning and contraception needs Regular monitoring appointments are important for assessing: Weight loss trajectory and body composition changes Nutritional status and dietary adequacy Cardiovascular parameters (blood pressure, heart rate) Mental health and wellbeing Effectiveness of ADHD management Blood glucose levels (particularly if you have diabetes or prediabetes) Liver and kidney function as clinically indicated NICE guidance on obesity management (TA875) and ADHD (NG87) emphasises the importance of comprehensive care

Predrag Sikiri, Sven Seiwerth, Ruman, R., Branko Turkovi, Dinko Stani Rokotov, Luka Bri, Sever, M., Kliek, R., Boo Radi, Domagoj Drmi, Spomenko Ili, Kolenc, D., Gorana Aralica, Safic, H., Jelena uran, Rak, D., Senka Didi, Hrvoje Vri, & Boidar ebei
The goal is evidence-based supplementation, not experimentation
SFN alleviates psoriasis via the KEAP1-NFE2L2 pathway Given the observed therapeutic effects of SFN, we sought to investigate the potential molecular mechanisms responsible for the therapeutic effect